Asensus Surgical jumps on tech deal with NVIDIA
rafal_olechowski

Asensus Surgical (NYSE:ASXC) added ~28% pre-market Thursday after announcing a collaboration with NVIDIA (NASDAQ:NVDA) to improve its Intelligent Surgical Unit (ISU), the foundation of the medical device maker's surgical systems.
As part of the deal, Asensus (ASXC) will use NVIDIA (NVDA) tools to advance the augmented intelligence capabilities of ISU.

Since 2021, Asensus (ASXC) has offered augmented intelligent features such as digital tags and 3D measurements as part of its ISU, which comes with NVIDIA's (NVDA) computing technology.
"Through this collaboration, Asensus is furthering its vision to enhance clinical intelligence in surgery through the use of advanced augmented intelligence tools," CEO Anthony Fernando said.
Per the terms, both Asensus (ASXC) and NVIDIA (NVDA) will jointly develop and commercialize digital surgical solutions, and both firms will get early access to relevant product roadmaps.



More on Asensus, Nvidia, etc.

AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley
Nvidia: Bull Case Is Stronger Than You May Think

NVIDIA Corp. (NVDA) Evercore ISI 2023 Semiconductor & Semiconductor Equipment Conference (Transcript)

NVIDIA Corporation (NVDA) Goldman Sachs Communacopia & Technology Conference
Nvidia: Taiwan Risks - Amidst Questionable Valuation Driven By Momentum
Nvidia Stock: It's Priced In
Nvidia's Blowout Quarter - But Gravity Always Wins
Nvidia Stock: Priced For Perfection (Rating Downgrade)
Nvidia: Warning Signs From The Latest Quarter
Google DeepMind co-founder says US should enforce AI standards for ethical use
Samsung stock rises on chip supply deal with Nvidia for use in AI - report
Biden Administration says it 'has not blocked' chip sales to Middle East